Clark, NJ, United States of America

Christopher Roberge


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 83(Granted Patents)


Location History:

  • Clark, NJ (US) (1996)
  • Westfield, NJ (US) (1998)
  • Cambridge, MA (US) (2001)

Company Filing History:


Years Active: 1996-2001

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Christopher Roberge: Innovator in Pharmaceutical Chemistry

Introduction

Christopher Roberge is a notable inventor based in Clark, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that aid in the treatment of benign prostatic hyperplasia. With a total of 5 patents to his name, Roberge's work has had a meaningful impact on medical science.

Latest Patents

One of Roberge's latest patents is focused on an enzymatic process for making alpha 1a adrenergic receptor antagonists using protease. This invention relates to crystalline pharmaceutically acceptable salts of an alpha 1a adrenergic receptor antagonist, Compound A, which are useful in treating benign prostatic hyperplasia. The patent also discloses pharmaceutical compositions employing these crystalline salts, along with processes for their synthesis and application. Furthermore, Roberge's invention includes a method for obtaining enantiomerically pure intermediates that are essential for synthesizing end product alpha 1a adrenergic receptor antagonists. These compounds are beneficial for relaxing lower urinary tract tissue.

Another significant patent involves the asymmetric bioreduction of a ketone substrate with yeast, which produces the corresponding (R)-alcohol. This alcohol serves as a key intermediate in the synthesis of a β3-agonist, showcasing Roberge's innovative approach to pharmaceutical development.

Career Highlights

Christopher Roberge is currently employed at Merck & Company, Inc., where he continues to advance his research in pharmaceutical chemistry. His work has been instrumental in developing new therapeutic options for patients suffering from various medical conditions.

Collaborations

Roberge has collaborated with esteemed colleagues, including Michel M Chartrain and John Y Chung. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in the pharmaceutical field.

Conclusion

Christopher Roberge is a distinguished inventor whose contributions to pharmaceutical chemistry have paved the way for new treatments in medicine. His innovative patents and collaborative efforts exemplify the importance of research and development in improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…